These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2345761)

  • 41. Blockade of ionotropic glutamatergic transmission in the ventral tegmental area attenuates the physical signs of morphine withdrawal in rats.
    Wang HL; Zhao Y; Xiang XH; Wang HS; Wu WR
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1079-87. PubMed ID: 15610920
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Morphine-dependent rats: blockade of precipitated abstinence by tetrahydrocannabinol.
    Hine B; Friedman E; Torrelio M; Gershon S
    Science; 1975 Feb; 187(4175):443-5. PubMed ID: 1167428
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methionine-enkephalin and beta-endorphin levels in spleen and thymus gland of morphine tolerant-dependent and abstinent rats.
    Bhargava HN; Ramarao P; Gulati A; Gudehithlu KP; Tejwani GA
    Life Sci; 1989; 45(26):2529-37. PubMed ID: 2533311
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prenatal exposure to morphine or naloxone intensifies morphine dependence at maturity.
    Koyuncuoğlu H; Aricioğlu F
    Pharmacol Biochem Behav; 1993 Apr; 44(4):939-41. PubMed ID: 8469703
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Suppression of naloxone-precipitated withdrawal jumps in morphine-dependent mice by stimulation of prostaglandin EP3 receptor.
    Nakagawa T; Minami M; Katsumata S; Ienaga Y; Satoh M
    Br J Pharmacol; 1995 Nov; 116(6):2661-6. PubMed ID: 8590986
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of different brain structures in the expression of the physical morphine withdrawal syndrome.
    Maldonado R; Stinus L; Gold LH; Koob GF
    J Pharmacol Exp Ther; 1992 May; 261(2):669-77. PubMed ID: 1578378
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The blockade of GABAA receptors attenuates the inhibitory effect of orexin type 1 receptors antagonist on morphine withdrawal syndrome in rats.
    Davoudi M; Azizi H; Mirnajafi-Zadeh J; Semnanian S
    Neurosci Lett; 2016 Mar; 617():201-6. PubMed ID: 26879836
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Orexin type 1 receptor antagonism in Lateral Paragigantocellularis nucleus attenuates naloxone precipitated morphine withdrawal symptoms in rats.
    Ahmadi-Soleimani SM; Ghaemi-Jandabi M; Azizi H; Semnanian S
    Neurosci Lett; 2014 Jan; 558():62-6. PubMed ID: 24211689
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration.
    Pinelli A; Cighetti G; Trivulzio S
    Fundam Clin Pharmacol; 2008 Aug; 22(4):439-45. PubMed ID: 18705754
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Calcium channel inhibitors suppress the morphine-withdrawal syndrome in rats.
    Bongianni F; Carla V; Moroni F; Pellegrini-Giampietro DE
    Br J Pharmacol; 1986 Jul; 88(3):561-7. PubMed ID: 3017487
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neonatal capsaicin modifies morphine withdrawal signs in the rat.
    Sharpe LG; Jaffe JH
    Neurosci Lett; 1986 Nov; 71(2):213-8. PubMed ID: 2431361
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evidence that opiate addiction is in part an immune response. Destruction of the immune system by irradiation-altered opiate withdrawal.
    Dafny N; Pellis NR
    Neuropharmacology; 1986 Aug; 25(8):815-8. PubMed ID: 3774111
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of peripheral and central administration of calcium channel blockers in the naloxone-precipitated abstinence syndrome in morphine-dependent rats.
    Baeyens JM; Esposito E; Ossowska G; Samanin R
    Eur J Pharmacol; 1987 May; 137(1):9-13. PubMed ID: 3609136
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of ibogaine on naloxone-precipitated withdrawal syndrome in chronic morphine-dependent rats.
    Dzoljic ED; Kaplan CD; Dzoljic MR
    Arch Int Pharmacodyn Ther; 1988; 294():64-70. PubMed ID: 3233054
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nicotine alleviation of nicotine abstinence syndrome is naloxone-reversible.
    Malin DH; Lake JR; Payne MC; Short PE; Carter VA; Cunningham JS; Wilson OB
    Pharmacol Biochem Behav; 1996 Jan; 53(1):81-5. PubMed ID: 8848464
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dextromethorphan attenuates post-ischemic hypoperfusion following incomplete global ischemia in the anesthetized rat.
    Tortella FC; Martin DA; Allot CP; Steel JA; Blackburn TP; Loveday BE; Russell NJ
    Brain Res; 1989 Mar; 482(1):179-83. PubMed ID: 2706475
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modification of the development of acute opiate tolerance by increased dopamine receptor sensitivity.
    Martin JR; Takemori AE
    J Pharmacol Exp Ther; 1987 Apr; 241(1):48-55. PubMed ID: 3572795
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Excitatory amino acid release in the locus coeruleus during naloxone-precipitated morphine withdrawal in adjuvant arthritic rats.
    Hoshi K; Yamamoto A; Ishizuki S; Fujihira E; Ichihara K
    Inflamm Res; 2000 Jan; 49(1):36-41. PubMed ID: 10778919
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of dextromethorphan on guinea pig ileal contractility in vitro: comparison with levomethorphan, loperamide and codeine.
    Kachur JF; Morgan DW; Gaginella TS
    J Pharmacol Exp Ther; 1986 Dec; 239(3):661-7. PubMed ID: 3795034
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Behavioral alterations produced by chronic naloxone injections.
    Malin DH; Layng MP; Swank P; Baker MJ; Hood JL
    Pharmacol Biochem Behav; 1982 Sep; 17(3):389-92. PubMed ID: 6890681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.